Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Novel APC-like properties of human NK cells directly regulate T cell activation
Jacob Hanna, … , Jane H. Buckner, Ofer Mandelboim
Jacob Hanna, … , Jane H. Buckner, Ofer Mandelboim
Published December 1, 2004
Citation Information: J Clin Invest. 2004;114(11):1612-1623. https://doi.org/10.1172/JCI22787.
View: Text | PDF | Retraction
Article Immunology

Novel APC-like properties of human NK cells directly regulate T cell activation

  • Text
  • PDF
Abstract

Initiation of the adaptive immune response is dependent on the priming of naive T cells by APCs. Proteomic analysis of unactivated and activated human NK cell membrane–enriched fractions demonstrated that activated NK cells can efficiently stimulate T cells, since they upregulate MHC class II molecules and multiple ligands for TCR costimulatory molecules. Furthermore, by manipulating antigen administration, we show that NK cells possess multiple independent unique pathways for antigen uptake. These results highlight NK cell–mediated cytotoxicity and specific ligand recognition by cell surface–activating receptors on NK cells as unique mechanisms for antigen capturing and presentation. In addition, we analyzed the T cell–activating potential of human NK cells derived from different clinical conditions, such as inflamed tonsils and noninfected and CMV-infected uterine decidual samples, and from transporter-associated processing antigen 2–deficient patients. This in vivo analysis revealed that proinflammatory, but not immune-suppressive, microenvironmental requirements can selectively dictate upregulation of T cell–activating molecules on NK cells. Taken together, these observations offer new and unexpected insights into the direct interactions between NK and T cells and suggest novel APC-like activating functions for human NK cells.

Authors

Jacob Hanna, Tsufit Gonen-Gross, Jonathan Fitchett, Tony Rowe, Mark Daniels, Tal I. Arnon, Roi Gazit, Aviva Joseph, Karoline W. Schjetne, Alexander Steinle, Angel Porgador, Dror Mevorach, Debra Goldman-Wohl, Simcha Yagel, Michael J. LaBarre, Jane H. Buckner, Ofer Mandelboim

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
MHC class II_restricted interactions between ANK and CD4+ T cells. (A) O...
MHC class II_restricted interactions between ANK and CD4+ T cells. (A) OFR3 CD4+ T cells were stained with PE-labeled DR0401 tetramer loaded with HA (DR0401-HA) or control peptide (DR0401-ospA) (gray histograms). Staining of freshly isolated CD4+ T cells with the same tetramers was used as a background setting (white histograms). (B and C) All APC_T cell incubations applied in the following experiments were maintained for 48 hours followed by addition of thymidine for an additional 24 hours. (B) Irradiated cells (50 × 103) were incubated with either HA306–318 (HA pep.) or control peptide (con pep.) (150 ng/ml) and added to the OFR3 T cell clone (50 × 103 cells per well). (C) Antigen-processing capability was tested by measurement of OFR3 clone proliferation in the presence of 150 ng/ml recombinant HA or BSA proteins (prot.). The contribution of CD80 and CD86 to OFR3 T cell activation was evaluated by pretreatment of APCs with 25 ng/ml CTLA-4Ig. (D) CD4+ T cells isolated from HLA-DR4+ donors were incubated for 10 days with UaNK or ANK cells pulsed with HA protein or BSA (indicated on the top of each panel), or only with recombinant HA protein. Cells were stained for CD4 and DR0401-HA or control DR0401-ospA tetramers. The percentage of tetramer-positive fraction out of total CD4+ T cells is indicated. Staining of PBLs from the same donor is shown as a control. One representative staining obtained from a single donor out of 3 donors examined is shown. (E) Naive umbilical cord_derived CD4+ T cells were cultured with HA- or BSA-pulsed ANK cells for 14 days and stained with DR4 peptide_loaded tetramers. (F) DR0401-HA_positive umbilical cord_derived CD4+ T cells were characterized for CD45RO and antigen-specific effector responses. At day 25 of coculturing, 150 × 103 cells from each donor were incubated for 96 hours with 150 × 103 irradiated autologous ANK cells either unpulsed or pulsed with HA or control peptide, in the presence of 2 μCi of [3H]thymidine per well. Prior to harvesting, supernatant was taken for measurement of IL-2 and IFN-γ. One representative characterization from a single donor out of 3 is shown. Values are mean ± SD for triplicate samples. **P < 0.01 by Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts